Chronic kidney disease and stroke.

Chronic kidney disease (CKD) is associated with an increased risk of both ischemic and hemorrhagic stroke. In addition to shared risk factors, this higher cerebrovascular risk is mediated by several CKD-associated mechanisms including platelet dysfunction, coagulation disorders, endothelial dysfunction, inflammation, and increased risk of atrial fibrillation. CKD can also modify the effect of treatments used in acute stroke and in secondary stroke prevention. We review the epidemiology and pathophysiology that link CKD and stroke and the impact of CKD on stroke outcomes. Interdisciplinary collaboration between nephrologists, pharmacists, hematologists, nutrition therapists, primary care physicians, and neurologists in providing care to these subjects may potentially improve outcomes.

[1]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[2]  A. Qureshi,et al.  Carotid Artery Stent Placement and Carotid Endarterectomy in Patients with Dialysis Dependent Renal Failure (P7.167) , 2014 .

[3]  Jung-Der Wang,et al.  Risk of stroke in long-term dialysis patients compared with the general population. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Tu,et al.  Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis , 2014, Circulation.

[5]  M. Turakhia,et al.  Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission? , 2014, JAMA.

[6]  J. Carrero,et al.  Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. , 2014, JAMA.

[7]  D. Kang,et al.  Homocysteine as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke , 2014, Stroke.

[8]  C. Kase,et al.  Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation , 2014, Neurology.

[9]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[10]  A. Power.  Stroke in Dialysis and Chronic Kidney Disease , 2013, Blood Purification.

[11]  D. Leys,et al.  IV thrombolysis and renal function , 2013, Neurology.

[12]  B. C. Kwan,et al.  Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[13]  M. Pencina,et al.  A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? , 2013, International journal of cardiology.

[14]  W. Schäbitz,et al.  Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants. , 2013, Stroke.

[15]  David W. Johnson,et al.  HMG CoA reductase inhibitors (statins) for dialysis patients. , 2009, The Cochrane database of systematic reviews.

[16]  Ravi S. Menon,et al.  Association of Chronic Kidney Disease With Cerebral Microbleeds in Patients With Primary Intracerebral Hemorrhage , 2013, Stroke.

[17]  A. Murray,et al.  Incidence of stroke before and after dialysis initiation in older patients. , 2013, Journal of the American Society of Nephrology : JASN.

[18]  J. Eikelboom,et al.  Stroke prevention in atrial fibrillation patients with chronic kidney disease. , 2013, The Canadian journal of cardiology.

[19]  M. Pencina,et al.  Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. , 2013, Pharmacological research.

[20]  J. Floege,et al.  Chronic kidney disease: How effective and safe are antiplatelet agents in CKD? , 2013, Nature Reviews Nephrology.

[21]  A. AbuRahma,et al.  Impact of chronic renal insufficiency using serum creatinine vs glomerular filtration rate on perioperative clinical outcomes of carotid endarterectomy. , 2013, Journal of the American College of Surgeons.

[22]  D. Owens,et al.  Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. , 2013, Journal of the American College of Cardiology.

[23]  J. Floege,et al.  Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Z. Massy,et al.  Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. , 2013, Journal of the American Society of Nephrology : JASN.

[25]  K. Farrington,et al.  Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease. , 2013, European heart journal.

[26]  H. Woo,et al.  Low Glomerular Filtration Rate Increases Hemorrhagic Transformation in Acute Ischemic Stroke , 2013, Cerebrovascular Diseases.

[27]  M. Keltai,et al.  Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. , 2012, European heart journal.

[28]  Peter Sandercock,et al.  Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 Studies , 2012, Stroke.

[29]  Keith C. Norris,et al.  Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  Eric E. Smith,et al.  Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator , 2012, Stroke.

[31]  I. Holme,et al.  Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population , 2012, Annals of medicine.

[32]  L. Køber,et al.  Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.

[33]  R. de Caterina,et al.  Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. , 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[34]  J. Hata,et al.  Proteinuria and clinical outcomes after ischemic stroke , 2012, Neurology.

[35]  R. Asinger,et al.  Warfarin in atrial fibrillation patients with moderate chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[36]  W. Winkelmayer,et al.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[37]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[38]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[39]  Bertram L Kasiske,et al.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). , 2011, Kidney international.

[40]  Candice L. Garwood,et al.  Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic , 2011, Journal of managed care pharmacy : JMCP.

[41]  M. Abdi,et al.  Common carotid artery intima-media thickness and atherosclerotic plaques in carotid bulb in patients with chronic kidney disease on hemodialysis: a case-control study. , 2011, Pakistan journal of biological sciences : PJBS.

[42]  Josef Coresh,et al.  Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[43]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[44]  Kortaro Tanaka,et al.  Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. , 2011, The American journal of cardiology.

[45]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[46]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[47]  D. Tanné,et al.  Chronic Kidney Disease in Patients with Acute Intracerebral Hemorrhage: Association with Large Hematoma Volume and Poor Outcome , 2010, Cerebrovascular Diseases.

[48]  Felix Yang,et al.  Warfarin in haemodialysis patients with atrial fibrillation: what benefit? , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[49]  Sarah E. Nelson,et al.  Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients , 2010, Journal of the American Heart Association.

[50]  K. Kario,et al.  Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry , 2010, Cerebrovascular Diseases.

[51]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[52]  Shen-Chih Chang,et al.  Low glomerular filtration rate and risk of stroke: meta-analysis , 2010, BMJ : British Medical Journal.

[53]  Satoko Nakamura,et al.  Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients , 2010, Journal of hypertension.

[54]  P. Kerr,et al.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.

[55]  A. Go,et al.  Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). , 2010, American heart journal.

[56]  P. McCullough,et al.  In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[57]  P. Ridker,et al.  Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. , 2010, Journal of the American College of Cardiology.

[58]  S. Yusuf,et al.  Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. , 2010, American heart journal.

[59]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[60]  W. Aronow,et al.  Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin , 2009, International journal of nephrology and renovascular disease.

[61]  R. Thadhani,et al.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.

[62]  N. Powe,et al.  Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[63]  D. Tanné,et al.  Chronic Kidney Disease and Clinical Outcome in Patients With Acute Stroke , 2009, Stroke.

[64]  D. Singer,et al.  Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2009, Circulation.

[65]  C. Anderson,et al.  Proteinuria and stroke: a meta-analysis of cohort studies. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[66]  Anita M Saran,et al.  Cardiovascular disease in chronic kidney disease , 2008, Therapeutic advances in cardiovascular disease.

[67]  F. Hatz,et al.  Renal function and outcome among stroke patients treated with IV thrombolysis , 2008, Neurology.

[68]  David W. Johnson,et al.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials , 2008, BMJ : British Medical Journal.

[69]  A. Hofman,et al.  Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study , 2007, Stroke.

[70]  P. Guarino,et al.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. , 2007, JAMA.

[71]  C. Guldener.  Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? , 2006 .

[72]  G. Remuzzi,et al.  Platelet dysfunction in renal failure. , 2004, Seminars in thrombosis and hemostasis.

[73]  V. Vaccarino,et al.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. , 2003, Kidney international.

[74]  L. Dember,et al.  Thrombosis in End‐Stage Renal Disease , 2003, Seminars in dialysis.

[75]  F. Sacks,et al.  Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency , 2003, Annals of Internal Medicine.

[76]  S. Fishbane,et al.  Increased bone fractures among elderly United States hemodialysis patients. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[77]  V. Howard,et al.  Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.